Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.020
+0.010 (0.99%)
At close: Mar 4, 2026, 4:00 PM EST
1.040
+0.020 (1.96%)
After-hours: Mar 4, 2026, 4:46 PM EST
Cardiol Therapeutics Employees
Cardiol Therapeutics had 18 employees as of December 31, 2024. The number of employees increased by 12 or 200.00% compared to the previous year.
Employees
18
Change
12
Growth
200.00%
Revenue / Employee
n/a
Profits / Employee
-$1,387,388
Market Cap
113.64M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 18 | - | - |
| Dec 31, 2018 | 6 | - | - |
| Sep 30, 2018 | 8 | - | - |
| Jun 30, 2018 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
| Lifecore Biomedical | 406 |
| Evolus | 329 |
| Anika Therapeutics | 288 |
| Alpha Teknova | 173 |
| Cumberland Pharmaceuticals | 91 |
| Assertio Holdings | 58 |
CRDL News
- 7 days ago - Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference - Newsfile Corp
- 22 days ago - Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure - Newsfile Corp
- 5 weeks ago - Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million - Newsfile Corp
- 6 weeks ago - Cardiol Therapeutics announces $13.5M bought-deal private placement - Seeking Alpha
- 6 weeks ago - Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Newsfile Corp
- 6 weeks ago - Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Newsfile Corp
- 7 weeks ago - Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis - Newsfile Corp
- 2 months ago - Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research... • news - Onvista